Rocket One Inc. Marketable Securities, Unrealized Gain (Loss)
Rocket One Inc. (RKTO) reported Marketable Securities, Unrealized Gain (Loss) of -$209.32 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2025-03-28
- Rocket One Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-12-31 was -$24.57K, a 107.82% decline year-over-year.
- Rocket One Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-09-30 was $0.00.
- Rocket One Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-06-30 was -$165.95K.
- Rocket One Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-03-31 was -$18.80K, a 185.67% decline year-over-year.
- Rocket One Inc. marketable securities, unrealized gain (loss) for fiscal 2023 was -$209.32K, a 274.62% decline from fiscal 2022.
- Rocket One Inc. marketable securities, unrealized gain (loss) for fiscal 2022 was $119.87K.
- Rocket One Inc. marketable securities, unrealized gain (loss) for fiscal 2021 was -$176.97K, a 450.08% decline from fiscal 2020.
- Rocket One Inc. marketable securities, unrealized gain (loss) for fiscal 2020 was $50.55K, a 1279.72% increase from fiscal 2019.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 6 month as first filed | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 9 month as first filed | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | -$24.57K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$24.57K derived: sum of 2 quarters · filed 2025-03-28 | -$190.52K derived: sum of 3 quarters · filed 2025-03-28 | -$209.32K 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$165.95K derived: sum of 2 quarters · filed 2024-11-12 | -$184.75K 10-Q · filed 2024-11-12 | $129.30K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$165.95K 10-Q · filed 2024-08-09 | -$184.75K 10-Q · filed 2024-08-09 | $129.30K derived: sum of 3 quarters · filed 2024-08-09 | $129.30K derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | -$18.80K 10-Q · filed 2024-05-14 | $295.25K derived: sum of 2 quarters · filed 2024-05-14 | $295.25K derived: sum of 3 quarters · filed 2024-05-14 | $79.12K derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $314.05K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $314.05K derived: sum of 2 quarters · filed 2024-03-28 | $97.92K derived: sum of 3 quarters · filed 2024-03-28 | $119.87K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$216.13K derived: sum of 2 quarters · filed 2023-11-13 | -$194.18K 10-Q · filed 2023-11-13 | -$132.06K 10-Q · filed 2022-11-10 | -$333.31K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$216.13K 10-Q · filed 2023-08-11 | -$194.18K 10-Q · filed 2023-08-11 | -$158.63K 10-Q · filed 2022-08-12 | -$333.31K derived: sum of 3 quarters · filed 2023-08-11 | -$323.74K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $21.95K 10-Q · filed 2023-05-15 | -$117.18K derived: sum of 2 quarters · filed 2023-05-15 | -$107.62K derived: sum of 3 quarters · filed 2023-05-15 | -$137.09K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$139.13K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$129.56K derived: sum of 2 quarters · filed 2023-03-31 | -$159.04K derived: sum of 3 quarters · filed 2023-03-31 | -$176.97K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $9.57K 10-Q · filed 2021-11-10 | -$19.91K derived: sum of 2 quarters · filed 2021-11-10 | -$37.84K 10-Q · filed 2022-11-10 | -$36.31K derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2021-06-30 | -$29.48K 10-Q · filed 2021-08-11 | -$47.41K 10-Q · filed 2022-08-12 | -$45.88K derived: sum of 3 quarters · filed 2022-05-12 | $171.00 derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2021-03-31 | -$17.93K 10-Q · filed 2022-05-12 | -$16.40K derived: sum of 2 quarters · filed 2022-05-12 | $29.65K derived: sum of 3 quarters · filed 2022-05-12 | $50.19K derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $1.53K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $47.58K derived: sum of 2 quarters · filed 2022-03-30 | $68.12K derived: sum of 3 quarters · filed 2022-03-30 | $50.55K 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $46.05K 10-Q · filed 2021-11-10 | $66.59K derived: sum of 2 quarters · filed 2021-11-10 | $49.02K 10-Q · filed 2021-11-10 | $48.29K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $20.54K 10-Q · filed 2021-08-11 | $2.97K 10-Q · filed 2021-08-11 | $2.24K derived: sum of 3 quarters · filed 2021-08-11 | |||
| 2020-03-31 | -$17.56K 10-Q · filed 2021-05-13 | -$18.30K derived: sum of 2 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$734.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $3.66K 10-K · filed 2021-03-16 | ||||
| 2019-09-30 | $4.40K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |